Evidence map›Paper›PMID 41303836›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Impact of Intervertebral Disc Degeneration and Endplate Changes on Cefazolin Penetration into the Intervertebral Disc.

Aleksejs Repnikovs, Kalvis Briuks, Artūrs Paulausks, Pēteris Studers, Konstantīns Logviss, Baiba Mauriņa, Dace Bandere, Jānis Kurlovičs, Sigita Kazūne

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aleksejs RepnikovsDepartment of Orthopaedics, Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0009-0003-5322-6863
Kalvis BriuksDepartment of Spine and Joint Surgery, Hospital of Traumatology and Orthopaedics, LV-1005 Riga, Latvia.
Artūrs PaulausksLaboratory of Finished Dosage Forms, Faculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-7446-1294
Pēteris StudersDepartment of Orthopaedics, Faculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-6403-8476
Konstantīns LogvissLaboratory of Finished Dosage Forms, Faculty of Pharmacy, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-4780-0852
Baiba MauriņaBaltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, LV-1048 Riga, Latvia.ORCID 0000-0001-9188-5681
Dace BandereBaltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, LV-1048 Riga, Latvia.ORCID 0000-0001-9144-8799
Jānis KurlovičsBioinformatics Group, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-4418-8055
Sigita KazūneDepartment of Anesthesiology and Intensive Care, Riga Stradins University, LV-1007 Riga, Latvia.ORCID 0000-0002-7010-3238

Funding

Fundamental and Applied Research Programme of the Latvian Council of Science lzp-2024/1/0303
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCefazolinIntervertebral DiscIntervertebral Disc DegenerationAdultAgedDiscitisDiskectomyFemaleHumansIntervertebral Disc DisplacementLumbar VertebraeMagnetic Resonance ImagingMaleMiddle AgedAnti-Bacterial AgentsCefazolinantibiotic prophylaxiscefazolindegenerative disc diseasespine surgery

Identifiers

PMID41303836
PMCPMC12654585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.